Clinical Trials Directory

Trials / Completed

CompletedNCT05703477

The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Fecal microbiota transplantation (FMT) achieves the purpose of treating intestinal and extra-intestinal diseases by transplanting the functional microbes in the feces of healthy people into the patient's intestine through the upper or lower alimentary tract routes to rebuild the patient's intestinal microbiota. Recently, FMT has been widely used in the treatment of various gastrointestinal diseases, including but not limit in CDI. In this study, we focused on the demonstration of FMT action mechanism in CDI treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREFecal microbiota transplantationFecal microbiota transplantation (FMT) achieves the purpose of treating intestinal and extra-intestinal diseases by transplanting the functional microbes in the feces of healthy people into the patient's intestine through the upper or lower alimentary tract routes to rebuild the patient's intestinal microbiota.

Timeline

Start date
2020-01-01
Primary completion
2022-08-30
Completion
2022-08-30
First posted
2023-01-30
Last updated
2024-01-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05703477. Inclusion in this directory is not an endorsement.